Catalyst Pharmaceuticals (CPRX) EPS (Weighted Average and Diluted) (2018 - 2026)
Catalyst Pharmaceuticals posted quarterly EPS (Weighted Average and Diluted) of $0.5 for Q1 2026, up 11.11% year-on-year from $0.45 in Q1 2025, and up 21.95% on a QoQ basis from $0.41 in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 9 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.5 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 11.11% year-over-year to $0.5; the trailing twelve-month figure through Mar 2026 stood at $1.74 (up 10.83% YoY), and the FY2025 full-year result was $1.68, up 28.24% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at $0.5, up from $0.41 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.5 in Q1 2026 and bottomed at -$0.29 in Q3 2023.
- The 5-year median for EPS (Weighted Average and Diluted) is $0.33 (2023), against an average of $0.29.
- The widest annual swing landed in 2023, when EPS (Weighted Average and Diluted) sank 245.0%; it then jumped 220.69% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.23 in 2022, then jumped by 34.78% to $0.31 in 2023, then soared by 41.94% to $0.44 in 2024, then slipped by 6.82% to $0.41 in 2025, then gained by 21.95% to $0.5 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at $0.5 (Q1 2026), $0.41 (Q4 2025), and $0.42 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.02 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.75 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.51 |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 0.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.50 |
| Dec 31, 2025 | 0.41 |
| Sep 30, 2025 | 0.42 |
| Jun 30, 2025 | 0.41 |
| Mar 31, 2025 | 0.45 |
| Dec 31, 2024 | 0.44 |
| Sep 30, 2024 | 0.35 |
| Jun 30, 2024 | 0.33 |
| Mar 31, 2024 | 0.19 |
| Dec 31, 2023 | 0.31 |
| Sep 30, 2023 | -0.29 |
| Jun 30, 2023 | 0.33 |
| Mar 31, 2023 | 0.26 |
| Dec 31, 2022 | 0.23 |
| Sep 30, 2022 | 0.20 |
| Jun 30, 2022 | 0.20 |
| Mar 31, 2022 | 0.12 |
| Dec 31, 2021 | 0.09 |
| Sep 30, 2021 | 0.10 |
| Jun 30, 2021 | 0.11 |
| Mar 31, 2021 | 0.07 |
| Dec 31, 2020 | 0.11 |
| Sep 30, 2020 | 0.41 |
| Jun 30, 2020 | 0.09 |
| Mar 31, 2020 | 0.10 |
| Dec 31, 2019 | 0.07 |
| Sep 30, 2019 | 0.13 |
| Jun 30, 2019 | 0.10 |
| Mar 31, 2019 | -0.01 |
| Dec 31, 2018 | -0.14 |
| Sep 30, 2018 | -0.08 |
| Jun 30, 2018 | -0.06 |